ArticleScientific reports2023
Joint triplet loss with semi-hard constraint for data augmentation and disease prediction using gene expression data.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An autoencoder and vision transformer based interpretability analysis on the performance differences in automated staging of second and third molars.Scientific reports · 2025Article
- Multi-task machine learning for transfusion decision support in acute upper gastrointestinal bleeding: a novel ensemble approach with clinical validation.Journal of translational medicine · 2025Article
- A review of AI-based radiogenomics in neurodegenerative disease.Frontiers in big data · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The accurate prediction of patients with complex diseases, such as Alzheimer's disease (AD), as well as disease stages, including early- and late-stage cancer, is challenging owing to substantial variability among patients and limited availability of clinical data. Deep metric learning has emerged as a promising approach for addressing these challenges by improving data representation. In this study, we propose a joint triplet loss model with a semi-hard constraint (JTSC) to represent data in a small number of samples. JTSC strictly selects semi-hard samples by switching anchors and positive samples during the learning process in triplet embedding and combines a triplet loss function with an angular loss function. Our results indicate that JTSC significantly improves the number of appropriately represented samples during training when applied to the gene expression data of AD and to cancer stage prediction tasks. Furthermore, we demonstrate that using an embedding vector from JTSC as an input to the classifiers for AD and cancer stage prediction significantly improves classification performance by extracting more accurate features. In conclusion, we show that feature embedding through JTSC can aid in classification when there are a small number of samples compared to a larger number of features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.